Australia, March 18 -- Sionna Therapeutics Inc., owns the trademark (2609396) for 'SIONNA THERAPEUTICS' till Sept. 8, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations; pharmaceutical preparations for the treatment of cystic fibrosis; pharmaceutical preparations for the treatment of genetic diseases or disorders; pharmaceutical preparations for the treatment of endocrine diseases or disorders; pharmaceutical preparations for the treatment of cellular diseases or disorders; pharmaceutical preparations for the treatment of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disorders.] and 42 [Pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; testing of pharmaceuticals; consulting services for others in the field of pharmaceutical research and development; consulting services for others in the field of pharmaceuticals research; research and development in the field of cystic fibrosis; research and development in the field of genetic diseases or disorders; research and development in the field of endocrine diseases or disorders; research and development in the field of cellular diseases or disorders; research and development in the field of pulmonary, respiratory, gastrointestinal, digestive, metabolic, and pancreatic diseases or disorders.]
Type of Mark: Word
Date of Acceptance: Dec. 23, 2025
Registration Advertised: March 17
For further details contact Keith Toms, Esq. McCarter & English LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2609396.
Disclaimer: Curated by HT Syndication.
